At Credo Diagnostics Biomedical, we help partners transform innovative concepts into market-ready molecular diagnostic solutions. Backed by more than a decade of experience in molecular diagnostics, assay development, reagent manufacturing, and Point-of-Care technologies, we provide comprehensive Contract Development and Manufacturing Organization (CDMO) services tailored to the evolving needs of the diagnostics industry.
From critical reagent development to scalable manufacturing, our integrated capabilities support every stage of the product lifecycle, helping partners accelerate development while maintaining quality, reliability, and performance.
Comprehensive CDMO Capabilities
Our end-to-end CDMO services include:
- Molecular assay design and development
- Enzyme production and purification
- Customized reagent formulation
- Lyophilized reagent development and manufacturing
- External control design and production
- Analytical performance optimization
- Stability and shelf-life studies
- Manufacturing scale-up and technology transfer
Through close collaboration and technical expertise, we help partners streamline product development and bring high-quality molecular diagnostic solutions to market efficiently.
Core Technology Expertise: Enzyme Development and Manufacturing
In molecular diagnostics, assay performance often begins with the quality of critical reagents. Among these components, enzymes play an essential role in ensuring accuracy, consistency, and workflow efficiency.
As part of our CDMO services, Credo Diagnostics Biomedical provides enzyme development and manufacturing solutions that support molecular diagnostic applications. Our expertise includes enzyme production, purification, formulation optimization, and scalable manufacturing processes.
One example is Amamus SM Nuclease, a non-specific endonuclease designed to efficiently degrade DNA and RNA. With high specific activity and robust performance across a wide range of operating conditions, it supports applications where effective nucleic acid degradation is required.
By combining enzyme expertise with assay development and manufacturing capabilities, we help partners build reliable and high-performing molecular diagnostic solutions.
Expertise in Lyophilized and Room-Temperature Stable Reagents
Credo Diagnostics Biomedical has extensive experience in developing lyophilized molecular reagents designed for room-temperature storage and transportation.
By reducing dependence on cold-chain logistics, our technologies simplify distribution, improve accessibility, and support the deployment of diagnostic solutions in decentralized and Point-of-Care settings.
These capabilities help partners improve product stability, optimize supply chain management, and expand access to molecular testing worldwide.
Supporting Diverse Diagnostic Applications
Our CDMO services support a broad range of molecular diagnostic applications, including:
- Infectious disease diagnostics
- Point-of-Care molecular testing
- Veterinary diagnostics
- Food safety testing
- Environmental monitoring
- Public health surveillance
- Specialized molecular diagnostic applications
Whether developing a new assay, optimizing an existing product, or expanding manufacturing capacity, Credo Diagnostics Biomedical provides flexible solutions tailored to each partner’s technical and commercial objectives.
Partnering for Meaningful Impact
At Credo Diagnostics Biomedical, we believe that innovative technologies have the greatest impact when they become accessible to the people who need them most.
By combining expertise in enzyme technologies, molecular assay development, lyophilization, and manufacturing, we help partners bring accurate, reliable, and accessible molecular diagnostic solutions to market faster.
Together, we are advancing molecular diagnostics to support better healthcare outcomes around the world.
